Conference | Session 2: New in Packaging Materials & Drug Delivery Systems


  • Dr. Joël Richard, Head of Technical and Pharmaceutical Operations, MedinCell
  • Dr. Kerstin Walke, Head Pharmaceutical Development Biologicals, Boehringer Ingelheim
All times displayed for Europe/Paris timezone.

A Game-Changing Delivery System for Long-Acting Injectables
13:30 - 13:50
Head of Technical and Pharmaceutical Operations

• BEPO(R) technology presentation
• High versatility: key formulation parameters for controlling drug release
• Major advantages versus classical long-acting injectable technologies
• Prospectives in the field of Long Acting formulations of fragile molecules

How will USP661.1 and ICH Q3D Impact your Packaging Materials Cocktail?
13:50 - 14:15
Regional Technical Manager Europe, Medical & Pharmaceutical products
Clariant Plastics and Coatings

• ICH Q3D and USP661.1 bring new requirements that could 'shake' the industry if not well prepared
• This regulation destroys the well-worn ‘food contact declarations are enough’
• Packaging supply chain will need to evaluate the impact of the new regulations
• USP661.1 taking full effect in May 2020, you might avoid to be ‘shaken’ into last-minute changes!

New Approaches to Manage Cost Effectively Highly Complex Small Scale Packaging and Single Patient Packs – Technology, Quality, Regulatory, and GMP Aspects
14:15 - 14:40
Senior Advisor Pharma & Health Care

• Managing complexity at small scale packaging and single patient packs
• Digitalisation and Industry 4.0 processes as enablers for cost effective packaging
• ICH Q12, Quality and Compliance Management

Parenteral Containers for Ophthalmic Applications: Challenges and Benefits of Glass-Coated Products for Intravitreal Injections
14:40 - 15:05
Director Corporate Account Management,
SiO2 Medical Products

• Challenges in the development of parenteral containers for ophthalmic applications / intravitreal injections
• Polymer Syringe with plasma deposited barrier coating and silicone-oil free lubricity coating
• EO sterilization study to show no gas migration into drug product
• Low particles

Discussion & Coffee Break
15:05 - 15:30